Cedience is a Canada-based startup founded in 2019 that aims to revolutionize the regulatory intelligence landscape for drug development teams. The company's slogan "AI-powered regulatory intelligence for drug development teams" reflects its core mission to leverage cutting-edge AI technology to address the complexities faced by regulatory teams. Utilizing natural language processing, machine learning, and generative AI technology, Cedience offers a next-generation regulatory intelligence platform that enables users to tackle intricate regulatory queries within seconds. Additionally, the platform provides robust monitoring, data extraction, comparison, summarization, and collaboration tools, catering to the diverse needs of regulatory teams. Recently, Cedience secured a Seed Round investment on 01 September 2023, with participation from Argon VC and Venture Lane. With its focus on the biopharma and biotechnology industries, Cedience stands as a promising player in the evolving landscape of regulatory intelligence solutions.
No recent news or press coverage available for Cedience.